Chen Mingjian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chen Mingjian has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Diming Zhao
Department of Cardiovascular Surgery, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College/National Center for Cardiovascular Diseases, Beijing, China
2 shared publications - Haochao Li
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037 Beijing, China
2 shared publications - Liqing Wang
Department of Cardiovascular Surgery, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College/National Center for Cardiovascular Diseases , 167 Beilishi Road, Xicheng District, Beijing 10037
2 shared publications - Pengfei Chen
Department of Cardiovascular Surgery, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College/National Center for Cardiovascular Diseases, Beijing, China
2 shared publications Liang Chen
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037 Beijing, China
1 shared publication- Liu Chenyu
Department of Cardiovascular Surgery, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College/National Center for Cardiovascular Diseases, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 18 February 2025
- Published by IMR Press in The Heart Surgery Forum
- Vol. 28 (2) , E194-E204
Blood Urea Nitrogen/Creatinine Ratio (BUR): A Novel Predictor of Early Prognosis in Acute Type A Aortic Dissection
Background: This study aims to evaluate the predictive value of the blood urea nitrogen/creatinine ratio (BUR) for the early prognosis of patients with acute type A aortic dissection (ATAAD) undergoing different surgical approaches. Methods: We examined clinical data from 250 patients diagnosed with ATAAD who underwent surgical treatment. Patients were divided into two groups based on the surgical approach: proximal repair and total arch replacement. The primary endpoints were in-hospital mortality, 30-day mortality, and acute kidney injury (AKI) analyzed in relation to BUR levels. Results: The receiver operating characteristic (ROC) curve for BUR demonstrated an area under the curve (AUC) of 0.72 for predicting in-hospital mortality, with an optimal cut-off value of 8.0. Patients with a BUR ≥8.0 were older, had a higher prevalence of hypertension and coronary artery disease, and exhibited a lower estimated glomerular filtration rate (eGFR) compared to those with a BUR <8.0. Multivariate analysis confirmed that a BUR ≥8.0 was an independent predictor of in-hospital mortality, 30-day mortality, and AKI. Kaplan-Meier survival analysis demonstrated that patients with a BUR ≥8.0 had significantly lower survival probabilities than those with a BUR <8.0, regardless of the surgical approach. The prognostic value of BUR was particularly pronounced in the total arch replacement group. Conclusions: The BUR is a novel and independent predictor of early prognosis in patients with ATAAD. It serves as a valuable tool for risk stratification and guide clinical decision-making, particularly in identifying high-risk patients prone to poor postoperative outcomes.
- 18 February 2025
- Published by IMR Press in The Heart Surgery Forum
- Vol. 28 (2) , E194-E204
Open AccessBlood Urea Nitrogen/Creatinine Ratio (BUR): A Novel Predictor of Early Prognosis in Acute Type A Aortic Dissection
Background: This study aims to evaluate the predictive value of the blood urea nitrogen/creatinine ratio (BUR) for the early prognosis of patients with acute type A aortic dissection (ATAAD) undergoing different surgical approaches. Methods: We examined clinical data from 250 patients diagnosed with ATAAD who underwent surgical treatment. Patients were divided into two groups based on the surgical approach: proximal repair and total arch replacement. The primary endpoints were in-hospital mortality, 30-day mortality, and acute kidney injury (AKI) analyzed in relation to BUR levels. Results: The receiver operating characteristic (ROC) curve for BUR demonstrated an area under the curve (AUC) of 0.72 for predicting in-hospital mortality, with an optimal cut-off value of 8.0. Patients with a BUR ≥8.0 were older, had a higher prevalence of hypertension and coronary artery disease, and exhibited a lower estimated glomerular filtration rate (eGFR) compared to those with a BUR <8.0. Multivariate analysis confirmed that a BUR ≥8.0 was an independent predictor of in-hospital mortality, 30-day mortality, and AKI. Kaplan-Meier survival analysis demonstrated that patients with a BUR ≥8.0 had significantly lower survival probabilities than those with a BUR <8.0, regardless of the surgical approach. The prognostic value of BUR was particularly pronounced in the total arch replacement group. Conclusions: The BUR is a novel and independent predictor of early prognosis in patients with ATAAD. It serves as a valuable tool for risk stratification and guide clinical decision-making, particularly in identifying high-risk patients prone to poor postoperative outcomes.
- Open Access
- 9 January 2025
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 20 (1) , 33
Global, Regional, and National Burden of Non-Rheumatic Valvular Heart Diseases in Women: A Systematic Analysis of Global Burden of Disease 1990–2021
Background: The incidence of non-rheumatic valvular heart diseases (NRVHD) has shown an increasing trend. However, most studies have overlooked the impact of gender on the disease. Female patients, as a specific subgroup, have rarely been discussed independently. It is essential to conduct separate epidemiological studies to understand the latest epidemiological data for female NRVHD patients and to raise awareness among researchers and clinicians. Methods: Data from the Global Burden of Disease (GBD) 2021 database were retrieved to obtain epidemiological data on female NRVHD from both global and regional perspectives, covering 204 countries and territories. Joinpoint regression, age-period-cohort analysis, decomposition, and predictive analyses were employed to further examine the epidemiological data. Results: The incidence of female NRVHD patients has shown a continuous upward trend and is expected to persist in the future, particularly in regions with high and high-middle Socio-Demographic Index (SDI). However, in low and lower-middle SDI regions, patients experience relatively higher Disability-Adjusted Life Years (DALYs) and Years Lived with Disability (YLDs), with a greater number of heart failure cases attributed to NRVHD. Decomposition analysis indicates that the increase in the incidence of NRVHD and its subtypes is primarily driven by population growth and aging. Conclusions: With economic development and population aging, female NRVHD remains a significant healthcare burden for countries worldwide. Low- and middle-SDI regions should implement tertiary prevention strategies to address the impending shift in the spectrum of valvular heart diseases. Further clinical research should focus on female patients as a distinct subgroup of NRVHD, exploring the unique aspects of the disease in this population.
- 9 January 2025
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 20 (1) , 33
Open AccessGlobal, Regional, and National Burden of Non-Rheumatic Valvular Heart Diseases in Women: A Systematic Analysis of Global Burden of Disease 1990–2021
Background: The incidence of non-rheumatic valvular heart diseases (NRVHD) has shown an increasing trend. However, most studies have overlooked the impact of gender on the disease. Female patients, as a specific subgroup, have rarely been discussed independently. It is essential to conduct separate epidemiological studies to understand the latest epidemiological data for female NRVHD patients and to raise awareness among researchers and clinicians. Methods: Data from the Global Burden of Disease (GBD) 2021 database were retrieved to obtain epidemiological data on female NRVHD from both global and regional perspectives, covering 204 countries and territories. Joinpoint regression, age-period-cohort analysis, decomposition, and predictive analyses were employed to further examine the epidemiological data. Results: The incidence of female NRVHD patients has shown a continuous upward trend and is expected to persist in the future, particularly in regions with high and high-middle Socio-Demographic Index (SDI). However, in low and lower-middle SDI regions, patients experience relatively higher Disability-Adjusted Life Years (DALYs) and Years Lived with Disability (YLDs), with a greater number of heart failure cases attributed to NRVHD. Decomposition analysis indicates that the increase in the incidence of NRVHD and its subtypes is primarily driven by population growth and aging. Conclusions: With economic development and population aging, female NRVHD remains a significant healthcare burden for countries worldwide. Low- and middle-SDI regions should implement tertiary prevention strategies to address the impending shift in the spectrum of valvular heart diseases. Further clinical research should focus on female patients as a distinct subgroup of NRVHD, exploring the unique aspects of the disease in this population.